SOLESENCE, INC. — Director's Dealing 2014

Feb 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2014-02-13

Reporting Person: CESARIO FRANK (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-13	Common Stock (right to buy)	$0.52	A	40000	Acquired	2024-02-13	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30450	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to buy)	$1.07	2019-06-24	Common Stock (20000)	20000	Direct
Common Stock (right to buy)	$1.70	2020-05-03	Common Stock (20000)	20000	Direct
Common Stock (right to buy)	$1.26	2021-05-02	Common Stock (31000)	31000	Direct
Common Stock (right to buy)	$0.30	2022-08-07	Common Stock (41000)	41000	Direct
Common Stock (right to buy)	$0.415	2023-02-14	Common Stock (39000)	39000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.